So who's actually the best for semaglutide?

One of the older, larger weight-care platforms — Found (Found Health Inc., joinfound.com) has operated since 2019 and reports 250,000+ members. Care is led by obesity-medicine clinicians and paired with a behavioral-coaching app, community and insurance navigation rather than medication alone. Its stand-out is breadth of formulary: compounded semaglutide at the entry, but also a genuine brand-name path (Wegovy, Ozempic) and oral Rybelsus (oral semaglutide), plus non-GLP oral options, all in 50 states with HSA/FSA accepted. The trade-off is pricing that varies and layers — the headline compounded rate (as low as $99/mo) needs a 3–12 month prepay, month-to-month lands nearer $199–$299/mo, and the brand path stacks a ~$39/mo membership on top of the drug.

Sesame is an established national telehealth marketplace (operating since 2018) rather than a single dedicated weight-loss program. You browse and choose your own licensed provider, see the price up front, and book — with a platform subscription billed on top of the medication, so the true monthly outlay is a two-part figure. Its stand-out is access: it carries the widest real brand-name GLP-1 lineup we log — Wegovy pen and Wegovy pill, Zepbound, Ozempic, Mounjaro and oral Rybelsus — including oral routes, all FDA-approved. It holds LegitScript certification and BBB accreditation and carries a large third-party review volume. The trade-off is that it is a generalist marketplace, not a weight-loss-specialized clinic, so ongoing coaching support is lighter, and brand-name cash prices can run high without insurance.

Sprout Health is a LegitScript-certified telehealth brand that pairs a low compounded entry point with a genuine brand-name route. Compounded semaglutide starts at $149/month and tirzepatide at $199/month (company-stated) and, unlike most compounders, it also offers a real brand-name Wegovy/Zepbound path. Intake is deliberately low-friction: no labs are required and often no telehealth visit either, so the start is close to frictionless. The trade-offs are transparency and scope — the compounded product is 503A-style and not FDA-approved, it is injectable only with no oral route, there is no named medical director, and state availability is gated behind a quiz.

A budget-first telehealth brand, and as of mid-2026 a more credible one than its price suggests. You complete an online intake, a licensed clinician signs off, and compounded semaglutide ships overnight, free, in all 50 states. Two things separate it from the usual cheap-sticker operator: it NAMES its compounding pharmacies — VialsRx (Texas Board of Pharmacy #35264) and GreenwichRx, with a certificate of analysis available on request — and it names the clinical network behind the prescriptions, Arora Health, along with its medical director. The price is flat at every dose. The catch is the commitment: $99 and $125 are annual-plan rates, and Trimi publishes no month-to-month figure at all.

Gala GLP-1 (operated by AI Coaching, Inc., with care delivered through OpenLoop-affiliated medical groups) is built as a women's brand — its pages read “for Women” and “dosed for women's bodies” — and it runs an online intake with clinician review, LegitScript-verified, prescribing in all 50 states as a bare claim with no state list published. It carries compounded semaglutide and tirzepatide, injection only, with no oral or sublingual route yet. Its prices sit on the public page rather than behind the intake, which is worth something — but read the asterisk. Every compounded figure on the page, $179/month for all doses and $149/month for the microdose alike, is footnoted “Price calculated based on a yearly subscription plan”, and the only other number the site gives is a $199/month FAQ rate on a three-month plan. Nothing is priced by the month. There is also a real brand-name door — FDA-approved Ozempic at $1,299/month cash — and a full HRT and menopause line under the same roof.

A compounded-only telehealth brand that leans on clear, published tiers rather than a hidden membership. Compounded semaglutide is $212/month — with a discounted $112 first month — and the price does not step up as you titrate to a higher dose. Care includes provider oversight and lab testing on a roughly six-month cadence, and there's a NAD+ add-on for people who want the longevity adjacency. It carries no brand-name or oral option, and it does not publish which states it serves.

A physician-supervised telehealth clinic for medical weight loss whose stand-out credential is LegitScript certification (#50087439) — an independent verification most compounded-semaglutide sellers do not carry. It fills compounded semaglutide (and tirzepatide) from U.S. pharmacies with transparent, no-insurance monthly pricing, and is one of the few brands we log that offers an oral semaglutide tablet alongside the usual injectable. The trade-offs are the usual compounded caveat plus a thin public site: some tiers are company-stated, the brand Ozempic route is an expensive pass-through, and the serviced-state count is not published.

A compounded-only telehealth brand whose pitch is format choice: sublingual semaglutide as well as the usual injectable, plus tirzepatide. Pricing is all-inclusive — medication, nurse support, shipping and follow-ups in one monthly rate, with no membership, no separate consult fee and cancellation at any time — and the injectable rates are published plainly on the product pages, holding flat whether you buy a 30- or a 90-day supply. Two things to go in knowing. The sublingual option that makes this brand interesting is not in the shop at all; it appears only in an FAQ answer, so the cheapest route is also the least documented. And the site does not agree with itself about its own size.

A compounded GLP-1 and longevity telehealth brand ("A New Era of Personalized Health") that publishes its prices openly rather than hiding them behind a quiz — a genuine plus, since many compounded rivals do not. You complete an online intake, a licensed clinician reviews it, and compounded semaglutide (or tirzepatide) ships as a weekly injectable. It carries both GLP-1 molecules and layers on a wider wellness menu — NAD+ and microdosing protocols — plus an optional Optimum membership that adds 1:1 coaching, a nutritionist, at-home lab draws and wearables. yourEra markets a 50-state licensed-clinician network with no insurance required and HSA/FSA accepted. The trade-offs are mid-market pricing, a compounded-only and injectable-only lineup, and a thin independent footprint — its 50-state and efficacy claims are self-reported.

Telos Rx (operated by Superior Health Solutions LLC) is a broad compounded-telehealth platform whose standout credential is LegitScript certification — an independent verification that most compounded-semaglutide sellers simply do not carry. Beyond GLP-1 it runs a wide menu: semaglutide and tirzepatide in both oral and microdosed formats, intranasal NAD+, recovery and growth-hormone peptides, and bioidentical HRT. The GLP-1 headline is genuinely low — microdosed semaglutide from about $49/month and tirzepatide from about $99/month — but those figures are annual-plan rates, so the cheapest numbers require a 6–12 month commitment, and pricing outside the GLP-1 line is quote-based rather than posted.

Bodybuilding Health+ is the compounded-telehealth arm of Bodybuilding.com — a licensed brand extension operated by Dynamo Group LLC that launched around April 2026. You complete an online intake, an independent licensed provider reviews it, and compounded semaglutide or tirzepatide is filled by a U.S. compounding pharmacy. Its GLP-1 pricing is public and competitive: semaglutide is $179 the first month (regularly $279) and steps down to $139/month on a 12-month bundle, with tirzepatide on the same $139 floor. Around the GLP-1 line sits an unusually deep menu for the lifter/longevity crowd — NAD+, sermorelin, ED and a broad peptide catalog. The trade-offs are newness and policy: it is only months old with a thin, mixed review record, and prescription orders are final sale.

Asynchronous telehealth: a U.S.-licensed physician reviews an online intake, usually inside a business day, and in many states no phone consultation is required at all. The distinguishing feature is route — the same semaglutide is sold as a sublingual lozenge or a weekly injection, and the lozenge is the cheaper of the two at $99/mo, so choosing the needle-free option costs less rather than more. Free physician visit, free shipping and free follow-up care are bundled instead of billed separately.

A deliberately stripped-back model: you buy a one- or three-month package rather than joining a subscription, there is no membership fee stacked on the medication, and the price is the same at every dose, so titrating up never raises the bill. Approval is same-day with no video call required. Available in all 50 states, and the intake is offered in Spanish as well as English.

A weight-loss platform rather than a single-format prescriber: compounded semaglutide and tirzepatide injections sit alongside GLP-1 liquid drops, lozenges and a daily oral pill, and genuine brand Wegovy and Zepbound are available for anyone who wants the FDA-approved product. Health coaching comes with the membership rather than being sold separately, and the company advertises a 120-day weight-loss guarantee. GLP-1s are prescribed in all 50 states.

LegitScript-verified compounded telehealth whose distinguishing feature is that it publishes the price at every dose — 0.25mg through 2.4mg all cost the same — so the cost of the dose you eventually titrate to is knowable on day one. A board-certified physician reviews the intake, medication ships overnight with injection supplies included, and if you are not prescribed you are refunded everything except a $39 physician-visit fee, stated before checkout. Oral semaglutide is offered alongside the injection.

Positioned on clinician access rather than price: unlimited appointments, unlimited messaging and 24/7 contact with a dedicated team are the headline, and its providers will prescribe FDA-approved brand medication where clinically appropriate rather than defaulting to compounded. The catch is disclosure — the site prices its longevity line publicly and its GLP-1 line not at all, so the monthly cost is unknowable until you are inside the intake.

A LegitScript-certified, HIPAA-compliant multi-service platform bundling weight loss with hair, TRT, sexual health and NAD+, so it suits someone consolidating several telehealth needs rather than buying semaglutide alone. Both routes are offered — compounded injectable plus oral Rybelsus — and a genuine brand Ozempic pathway sits beside them. The weakness is disclosure: one “from $199/mo” covers every weight-loss treatment, and per-dose figures only appear once you are through the intake quiz.

A LegitScript-certified nationwide programme whose pricing only appears once you are inside the intake — the public site advertises weight-loss injections from $199 without naming which molecule that buys. What you get is genuinely all-in: consult, medication, supplies, shipping and support in one figure, with nothing charged until a provider has approved you and the consult free if you proceed. The catch is dose. Every quoted figure is for the lowest dosage, and the funnel says outright that higher doses may cost more, so the number you see at signup is a floor rather than the price of a therapeutic dose.

A telehealth weight-management platform offering compounded semaglutide in two routes — a weekly injection and an oral dissolving tablet — alongside compounded tirzepatide, four branded pens (Wegovy, Ozempic, Mounjaro, Zepbound) and sermorelin. Onboarding is a two-minute quiz reviewed by a licensed provider. The catalogue is genuinely broad; what is missing is any price. Nothing on the public site quotes a figure for any product, its pricing page returns a 404, and every route to a number runs through the intake. Two further claims on its own homepage do not survive reading the rest of it.

Online intake with a licensed provider, with compounded semaglutide shipped to your door if prescribed. The advertised $99/month covers medication only; an active Eden Membership is required and billed separately, so the real monthly outlay is the sum of the two.

Membership-based telehealth with access to a physician and dietitian plus nutrition coaching. Compounded injectable semaglutide is an add-on priced on top of the membership, so the total monthly cost is the membership fee plus the medication fee.

Large telehealth platform offering brand-name Wegovy, Ozempic and Zepbound (insurance or cash-pay) alongside other GLP-1 options. The Ro Body membership is billed on its own; the company states the cost of GLP-1 medication is not included and varies by treatment and insurance.

Large telehealth platform that, following a 2026 settlement with Novo Nordisk, has pivoted to brand-name FDA-approved options — Wegovy, oral Wegovy and Zepbound — as an authorized distribution channel (its legacy compounded semaglutide is being phased out by mid-2026). The membership is billed on its own; the medication is a separate cost on top, so there is no single flat figure.

Telehealth provider that prescribes compounded injectable and oral semaglutide filled through its pharmacy network, with clinician support and free shipping. Unlike a true flat plan, the monthly price steps up by about $100 once you pass the 1mg dose, and the lowest advertised figures require a longer-term bundle commitment.

Pairs clinical GLP-1 care — compounded semaglutide or brand-name Wegovy/Zepbound — with the all-inclusive Noom behavioral app. The introductory rate is attractive, but the standard program price steps up sharply to $349/month after the intro period, and the app value can make the underlying medication cost harder to see.

The clinical arm of WeightWatchers (formerly Sequence) pairs clinician care and the WW behavioral program with brand-name Wegovy, oral Wegovy, Saxenda and Zepbound — it dropped compounded GLP-1s in 2025. The program fee is separate from the medication, which is largely insurance-dependent, so your true monthly total depends on your coverage.

This is not a telehealth programme; it is a dispensing pharmacy owned by the company that makes the drug. You bring a prescription — Novo will point you at a referral service but does not name or employ a prescriber — and NovoCare fills brand-name Wegovy and ships it to your door, billed monthly with no membership, consult or lab fee alongside it. Self-pay is $199/month for the first two fills for patients new to the offer and $349/month after that for the 0.25–2.4 mg pens, $399/month for the 7.2 mg HD pen, and $149/month for the oral Wegovy pill at 1.5 mg or 4 mg. With commercial insurance the savings card can take the monthly cost to as little as $25, capped at $100/month of savings.

Calibrate sells the wrap-around, not the vial. $199/month buys a 20-minute video visit with a prescribing clinician, 1:1 video coaching across food, sleep, exercise and emotional health, and insurance navigation — and it prescribes only FDA-approved brand products (Wegovy, Ozempic, Mounjaro, Zepbound, Foundayo), never a compounded copy. The medication is billed separately and Calibrate publishes no price for it: the model assumes your commercial insurance pays, and the site states most insured members should land at $25/month or less after any deductible. There is no published self-pay fallback if your plan says no. The membership itself is HSA/FSA eligible but explicitly not covered by insurance, and it carries a stated “+10% weight loss guaranteed or you're eligible for money back”.

An established national telehealth platform (LMND Medical Group, Inc.) whose weight programme runs on a mandatory $49/month membership covering clinician consults, ongoing care and one lab order a year, with the medication billed on top. Compounded semaglutide is $299/month month-to-month or $249/month on a three-month prepay, and Lemonaid markets it as pricing that does not change with your dose. A cheaper $199/month tier exists but is a microdose, capped by Lemonaid's own definition at a quarter of the standard maintenance dose. Brand Wegovy and Ozempic are available at four-figure cash prices. Care is delivered by video or phone rather than pure async, and — unusually for a platform this size — the weight-loss programme is explicitly not available in all fifty states.

A straightforward compounded-only programme: complete an online assessment, a board-certified U.S.-licensed clinician decides whether to prescribe, and the medication ships. The price is one flat rate that does not move as you titrate — $199/month after a $99 first month — and it covers the medication, the provider access and shipping, with no membership stacked underneath. LegitScript-certified, and its own pages carry the compounded disclaimer in plain terms. The gaps are geographic and informational: it does not ship to Alaska, Mississippi, New Jersey or Kansas, and it never names the pharmacy that compounds what you are injecting.

Curex (Curex, Inc.) started as an allergy-immunotherapy company and now runs a GLP-1 line alongside it. What makes it worth a look on a semaglutide site is the route choice: the same plan covers a weekly compounded injection or an oral dissolving tablet, which is unusual, and California is served on the oral route only. There is no membership fee — the page states $0 — and free shipping is included, with a full refund if a clinician does not prescribe. What is missing is per-drug transparency: the site anchors everything to a single “from $199/mo” plan figure and a $49 first-month sale, and never publishes what an individual medication costs in an ongoing month.

Effecty LLC sells compounded GLP-1 injections on a commitment ladder — $195/month if you pay monthly, $175/month on a three-month supply, $145/month if you prepay a year — and, unusually, publishes brand-name cash prices on the same page rather than hiding them: Ozempic at $1,300/month, Wegovy at $1,600/month, Zepbound at $1,400/month. That side-by-side is genuinely useful, because it is the clearest statement on this board of what the compounded discount is actually worth. It is LegitScript-certified and ships nationwide. What it does not publish is whether the price moves as your dose climbs, or what its promotional code actually applies to.

Alan Health Technologies, Inc. (trading as Alan Meds) is the format specialist here: personalised compounded semaglutide as a weekly injection, the same drug as a microdose injection, an oral compounded route, and a microdose oral dissolving tablet — four ways to take one molecule, each with its own price. The standard injection is $315/month at the regular rate and $158/month if you pay two months up front; microdoses are $125/month injected and $99/month as a tablet; the full oral route is $305/month regular and from $215/month on six-month plans. Brand Wegovy is listed at $1,695. It is LegitScript-verified and says its medications come from U.S. 503A and 503B pharmacies, though it names none of them and publishes no state list.

VitaraRx publishes the simplest price structure on this board: $99/month for compounded semaglutide, with “All doses. Same Price.” stated against the 0.25–2.5 mg range and no first-month rate, membership or prepay tier attached to it. It is LegitScript-verified and carries the compounded-medication disclaimer plainly. The reason it is not higher up is disclosure rather than price: the site describes itself as “a marketplace platform” rather than a clinic, publishes no legal entity, no served-state list, no lab policy and no statement of what the $99 actually covers beyond the medication.

EverSlim runs a deliberately simple offer: one price that its own page says covers the provider visit, the prescription and the delivery, quoted from $117/month for compounded semaglutide and from $140/month for compounded tirzepatide. Coverage is the detail worth knowing — it operates in all fifty states plus DC, but only 44 of those jurisdictions allow the asynchronous questionnaire route; the other seven require a live provider consultation before anything is prescribed. It is LegitScript-certified. The corporate picture is thin: the footer names “CareGLP Affiliated P.C.s” and an affiliated network of medical professional corporations rather than one company, and the compounding pharmacy is not identified.